CDK2-IN-53
CDK2-IN-53 (compound 9) is a CDK2 inhibitor with anticancer properties. It selectively inhibits the proliferation of HCT-116 and MCF-7 cells, with IC50 values of 13.89 μM and 7.65 μM, respectively, while demonstrating lower cytotoxicity to normal lung fibroblasts (WI-38) (IC50= 71.24 μM) . CDK2-IN-53 is applicable in research on cancers such as colon and breast cancer.
Product Specifications
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
D4015-16A-01 20 µg
DnaK, CT, aa385-638, Substrate Binding Domain, Recombinant discontinued, see D4015-16
Sign In for Pricing
View Details D4015-16A-02 100 µg
DnaK, CT, aa385-638, Substrate Binding Domain, Recombinant discontinued, see D4015-16
Sign In for Pricing
View Details 138129-APC 100 µL
MHC Class II, beta Chain (MHC Class II beta Chain, MHC Class II, MHC II) (APC) discontinued
Sign In for Pricing
View Details 
MBS1191578-01 0.02 mg (E-Coli)
Recombinant Listeria welshimeri serovar 6b Diaminopimelate epimerase (dapF)
Sign In for Pricing
View Details